லக்சை வாழ்க்கை அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

City-based firm gets DGCI nod for phase 2 drug trials

Council of Scientific &amp; Industrial Research (CSIR), and city-based Laxai Life Sciences have been given the regulatory approval by Drugs Controller General of India (DGCI) to undertake a two-ar

Jammu and kashmirAndhra pradeshRam upadhayayIndian institute of integrative medicineLaxai life sciencesCouncil of scientific industrial researchIndian institute of chemical technologyIndustrial researchDrugs controller generalIndian instituteChemical technologyIntegrative medicineCsir dgci covid 19 colchicineஜம்மு மற்றும் காஷ்மீர்ஆந்திரா பிரதேஷ்இந்தியன் நிறுவனம் ஆஃப் ஒருங்கிணைந்த மருந்து

CSIR, Laxai Life Sciences to undertake trials on COVID-19 patients with Colchicine

CSIR, Laxai Life Sciences to undertake trials on COVID-19 patients with Colchicine
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

Jammu and kashmirAndhra pradeshRam vishwakarmaLaxai life sciences pvtCsir indian institute of integrative medicineCouncil of scientific industrial researchCsir indian institute of chemical technologyIndustrial researchLaxai life sciencesIndian instituteChemical technologyIntegrative medicineஜம்மு மற்றும் காஷ்மீர்ஆந்திரா பிரதேஷ்ரேம் விஸ்வகர்மாலக்சை வாழ்க்கை அறிவியல் பிரைவேட்

CSIR in partnership with Laxai Life Sciences has received regulatory approval to undertake clinical trials on Covid-19 patients with Colchicine

New Delhi: Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd. Hyderabad, have been given the regulatory approval by DCGI to undertake a two-arm phase-II clinical trial to assess the safety and efficacy of the dr

Jammu and kashmirAndhra pradeshNew delhiRam upadhayayRam vishwakarmaShekharc mandeLaxai life sciences pvtCsir indian institute of integrative medicineCouncil of scientific industrial researchCsir indian institute of chemical technologyIndustrial researchLaxai life sciencesIndian instituteChemical technologyIntegrative medicineDirector general

CSIR gets drug regulator s nod for clinical trial of Colchicine on Covid-19 patients

The Drugs Controller General of India has approved the Phase-II trial of Colchicine, which can help Covid-19 patients with co-morbidities related to heart and also for their faster recovery.

Jammu and kashmirAndhra pradeshRam vishwakarmaRam upadhayayShekharc mandeCouncil of scientificCsir indian institute of integrative medicineLaxai life sciencesHyderabad laxai life sciences privateCsir indian institute of chemical technologyIndustrial researchLaxai life sciences private limitedDrugs controller generalIndian instituteChemical technologyIntegrative medicine

Regulatory nod for conducting clinical trials of Colchicine on COVID-19 patients: CSIR

CSIR institutes partners in this important clinical trial are the CSIR-IICT, Hyderabad and CSIR-IIIM, Jammu.

Jammu and kashmirAndhra pradeshRam vishwakarmaRam upadhayayLaxai life sciences pvt ltdLaxai life sciences pvt ltd hyderabadCsir indian institute of integrative medicineLaxai life sciencesCouncil of scientific industrial researchCsir indian institute of chemical technologyDrugs controller generalIndustrial researchIndian instituteChemical technologyIntegrative medicineLife sciences